Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SLF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PRRC2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MCAT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM64 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CYLD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GNA11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101927266 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TXLNG - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CEMP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
HDLBP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRMT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAP3K2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SAP30BP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WDR6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SSX2IP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TYW5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CANT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EWSR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRABD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MKKS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on